Detalhe da pesquisa
1.
HLA-E-restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD.
Blood
; 141(13): 1560-1573, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477802
2.
Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation.
Am J Transplant
; 24(5): 743-754, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097018
3.
The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics.
Am J Transplant
; 24(3): 338-349, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38032300
4.
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients.
J Am Soc Nephrol
; 34(1): 160-174, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36137752
5.
Post-Transplant Surveillance and Management of Chronic Active Antibody-Mediated Rejection in Renal Transplant Patients in Europe.
Transpl Int
; 36: 11381, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37529383
6.
Morphologic and Molecular Features of Antibody-Mediated Transplant Rejection: Pivotal Role of Molecular Injury as an Independent Predictor of Renal Allograft Functional Decline.
Transpl Int
; 36: 12135, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38169771
7.
Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes.
Am J Transplant
; 22(8): 1976-1991, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575435
8.
Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials.
Expert Opin Emerg Drugs
; 27(2): 151-167, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35715978
9.
Critical Role of Neprilysin in Kidney Angiotensin Metabolism.
Circ Res
; 127(5): 593-606, 2020 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32418507
10.
Levels of donor-derived cell-free DNA and chemokines in BK polyomavirus-associated nephropathy.
Clin Transplant
; 36(11): e14785, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35894263
11.
Alloimmune Risk Stratification for Kidney Transplant Rejection.
Transpl Int
; 35: 10138, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35669972
12.
Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation.
Transpl Int
; 35: 10135, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35669975
13.
Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation.
Transpl Int
; 35: 10140, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35669973
14.
Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection.
J Am Soc Nephrol
; 32(11): 2743-2758, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253587
15.
A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection.
J Am Soc Nephrol
; 32(3): 708-722, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33443079
16.
Factors associated with kidney graft survival in pure antibody-mediated rejection at the time of indication biopsy: Importance of parenchymal injury but not disease activity.
Am J Transplant
; 21(4): 1391-1401, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594646
17.
Discovering novel injury features in kidney transplant biopsies associated with TCMR and donor aging.
Am J Transplant
; 21(5): 1725-1739, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33107191
18.
Renal allograft DARCness in subclinical acute and chronic active ABMR.
Transpl Int
; 34(8): 1494-1505, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33983671
19.
Anti-interleukin-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism.
Transpl Int
; 34(8): 1542-1552, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153143
20.
Diagnostic value of donor-derived cell-free DNA to predict antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients.
Transpl Int
; 34(9): 1689-1702, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34448270